Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

15.10
Delayed Data
As of Feb 23
 0.00 / 0.00%
Today’s Change
7.86
Today|||52-Week Range
19.90
+0.33%
Year-to-Date
Clovis (CLVS) Q4 Loss Wider than Expected; Focus on Rubraca
Feb 23 / Zacks.com - Paid Partner Content
Sarepta Leads Biotech Movers on Voucher Deal News
Feb 21 / TheStreet.com - Paid Partner Content
Momenta Pharmaceuticals, Inc. Earnings Take a Back Seat
Feb 22 / MotleyFool.com - Paid Partner Content
Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS
Feb 20 / Zacks.com - Paid Partner Content
Momenta Tops Q4 Earnings, Shares Down on Warning Letter
Feb 22 / Zacks.com - Paid Partner Content
Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks
Feb 16 / MotleyFool.com - Paid Partner Content
Analysts' Actions -- Discovery, First Solar, Momenta, VF Corp. and More
Feb 22 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: MidWestOne Financial Group, Brooks Automation, Cro...
Feb 14 / Zacks.com - Paid Partner Content
Why Momenta Pharmaceuticals, Northern Dynasty Minerals, and Unilever Slumped Today
Feb 21 / MotleyFool.com - Paid Partner Content
Forget Gilead, Buy These 5 Biotech Stocks Instead
Feb 13 / Zacks.com - Paid Partner Content
Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today
Feb 21 / MotleyFool.com - Paid Partner Content
5 Stocks to Buy as Trump Chalks Out 'Phenomenal' Tax Plan
Feb 13 / Zacks.com - Paid Partner Content
Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today
Feb 21 / MotleyFool.com - Paid Partner Content